Coologics Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$1M
- Investors
-
8
Coologics General Information
Description
Developer of a medical device designed for the treatment of vaginal infections. The company's technology utilizes a patented controlled-cooling mechanism to target biological drivers of infection, including fungal activity and inflammation, enabling medical practitioners to provide women with a drug-free alternative to traditional antifungal treatments that restores the vaginal environment to a healthy state.
Contact Information
Website
www.vlisse.comCorporate Office
- 1 Eagle Valley Court
- Suite 101
- Broadview Heights, OH 44147
- United States
Corporate Office
- 1 Eagle Valley Court
- Suite 101
- Broadview Heights, OH 44147
- United States
Coologics Timeline
Coologics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC | 10-Sep-2026 | $1M | Completed | Generating Revenue | ||
| 2. Seed Round | 23-Apr-2025 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | 03-Oct-2024 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Coologics Patents
Coologics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220175575-A1 | Methods and devices for personal care including menstruation and microbial infections | Pending | 30-Nov-2017 | ||
| US-20210106461-A1 | Medical conditions in body cavities | Pending | 28-Mar-2010 | ||
| US-10639189-B2 | Treating conditions caused by abnormal growth of pathogens in body cavities | Active | 28-Mar-2010 | ||
| US-20140058326-A1 | Treating conditions caused by abnormal growth of pathogens in body cavities | Active | 28-Mar-2010 | ||
| US-20200214882-A1 | Treating conditions caused by abnormal growth of pathogens in body cavities | Pending | 28-Mar-2010 | A61F7/12 |
Coologics Signals
Coologics Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bold Fund Management | Venture Capital | Minority | ||
| Dream Ventures | Venture Capital | Minority | ||
| Illini Angels | Angel Group | Minority | ||
| Illinois Ventures | Venture Capital | Minority | ||
| Oakwood Circle Ventures | Venture Capital | Minority |
Coologics FAQs
-
When was Coologics founded?
Coologics was founded in 2019.
-
Where is Coologics headquartered?
Coologics is headquartered in Broadview Heights, OH.
-
What is the size of Coologics?
Coologics has 9 total employees.
-
What industry is Coologics in?
Coologics’s primary industry is Therapeutic Devices.
-
Is Coologics a private or public company?
Coologics is a Private company.
-
What is Coologics’s current revenue?
The current revenue for Coologics is .
-
How much funding has Coologics raised over time?
Coologics has raised $4M.
-
Who are Coologics’s investors?
Bold Fund Management, Dream Ventures, Illini Angels, Illinois Ventures, and Oakwood Circle Ventures are 5 of 8 investors who have invested in Coologics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process